RAPID COMMUNICATION

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

Authors

Tetsuo Kubota¹, Tokiko Nii¹, Toshihiro Nanki², Hitoshi Kohsaka², Masayoshi Harigai², Yukiko Komano², Takahiko Sugihara², Yoshinori Nonomura², Wataru Hirose³, Kenji Nagasaka⁴, Tetsushi Sakurai⁵ and Nobuyuki Miyasaka²

1. Tokyo Medical and Dental University Graduate School of Health Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
2. Department of Medicine and Rheumatology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
3. Hirose Clinic, Tokorozawa, Japan
4. Ome Municipal General Hospital, Ome, Japan
5. Sakurai Clinic, Ome, Japan

Received:

22 May 2007

Accepted:

26 June 2007

Full Text

Download (PDF) （member's only）

Abstract

Without Abstract

Key words

Etanercept - Infliximab - Influenza vaccine